Hudson Valley Investment Advisors’s Opus Genetics IRD Stock Holding History

Hudson Valley Investment Advisors’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-417	Closed	-$9.42K	–	174
2019 Q1	$10K	Buy	+417	New	+$13.8K	﹤0.01%	159
2018 Q4	–	Sell	-417	Closed	-$36K	–	167
2018 Q3	$36K	Hold	417	–	–	0.01%	142
2018 Q2	$28K	Hold	417	–	–	0.01%	150
2018 Q1	$30K	Hold	417	–	–	0.01%	148
2017 Q4	$40K	Hold	417	–	–	0.01%	146
2017 Q3	$48K	Hold	417	–	–	0.01%	146
2017 Q2	$57K	Hold	417	–	–	0.02%	142
2017 Q1	$102K	Hold	417	–	–	0.03%	144
2016 Q4	$28K	Hold	417	–	–	0.01%	147
2016 Q3	$42K	Hold	417	–	–	0.01%	146
2016 Q2	$50K	Hold	417	–	–	0.02%	146
2016 Q1	$66K	Hold	417	–	–	0.02%	140
2015 Q4	$73K	Buy	+417	New	+$88.7K	0.02%	144
2015 Q3	–	Sell	-417	Closed	-$122K	–	161
2015 Q2	$122K	Buy	+417	New	+$142K	0.04%	140

Other funds holding IRD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hudson Valley Investment Advisors's IRD Position: Q2 2019 in Review

Hudson Valley Investment Advisors sold out of Opus Genetics (IRD) in Q2 2019, closing a stake of 417 shares — an estimated $9.42K sold.

Hudson Valley Investment Advisors first reported a position in IRD in Q2 2015 and held it in 14 quarters. The position peaked at $122K in Q2 2015. 16 funds tracked by Wall St. Rank hold IRD as of Q2 2019.

Hudson Valley Investment Advisors reported no remaining Opus Genetics position as of Q2 2019 after selling out during the quarter.
Hudson Valley Investment Advisors sold 417 Opus Genetics shares in Q2 2019, an estimated $9.42K.
Hudson Valley Investment Advisors first reported a position in Opus Genetics in Q2 2015 and held it in 14 quarters.
Hudson Valley Investment Advisors's Opus Genetics position peaked at $122K in Q2 2015.
16 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2019.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2019, filed 16 Jul 2019.